312 related articles for article (PubMed ID: 34066081)
1. Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.
Kovacikova L; Prnova MS; Majekova M; Bohac A; Karasu C; Stefek M
Molecules; 2021 May; 26(10):. PubMed ID: 34066081
[TBL] [Abstract][Full Text] [Related]
2. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.
Grewal AS; Bhardwaj S; Pandita D; Lather V; Sekhon BS
Mini Rev Med Chem; 2016; 16(2):120-62. PubMed ID: 26349493
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase inhibitors: 2013-present.
Quattrini L; La Motta C
Expert Opin Ther Pat; 2019 Mar; 29(3):199-213. PubMed ID: 30760060
[TBL] [Abstract][Full Text] [Related]
4. Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications.
Kumar M; Choudhary S; Singh PK; Silakari O
Future Med Chem; 2020 Jul; 12(14):1327-1358. PubMed ID: 32602375
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine.
Elmazoglu Z; Prnova MS; Stefek M; Ceylan AF; Aschner M; Rangel-López E; Santamaria A; Karasu C
Neurotox Res; 2021 Jun; 39(3):588-597. PubMed ID: 33713301
[TBL] [Abstract][Full Text] [Related]
6. Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.
Juskova M; Majekova M; Demopoulos V; Stefek M
Gen Physiol Biophys; 2011 Dec; 30(4):342-9. PubMed ID: 22131315
[TBL] [Abstract][Full Text] [Related]
7. Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.
Huang Q; Liu Q; Ouyang D
Med Chem; 2019; 15(1):3-7. PubMed ID: 29792152
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of indole-substituted thiosemicarbazones as an aldose reductase inhibitor: an
Shehzad MT; Khan A; Halim SA; Hameed A; Imran A; Iqbal J; Ullah A; Asari A; Khan S; Shafiq Z; Al-Harrasi A
Future Med Chem; 2021 Jul; 13(14):1185-1201. PubMed ID: 34148377
[No Abstract] [Full Text] [Related]
9. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity.
Zhu S; Zhang S; Hao X; Qin X; Parveen S; Yang S; Ma B; Zhu C
J Enzyme Inhib Med Chem; 2016; 31(sup1):126-130. PubMed ID: 27153454
[TBL] [Abstract][Full Text] [Related]
10. Potential use of aldose reductase inhibitors to prevent diabetic complications.
Zenon GJ; Abobo CV; Carter BL; Ball DW
Clin Pharm; 1990 Jun; 9(6):446-57. PubMed ID: 2114249
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
Bhadada SV; Vyas VK; Goyal RK
Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
[TBL] [Abstract][Full Text] [Related]
12. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
[TBL] [Abstract][Full Text] [Related]
13. Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition.
Javid N; Munir R; Chaudhry F; Imran A; Zaib S; Muzaffar A; Iqbal J
Bioorg Chem; 2020 Jun; 99():103852. PubMed ID: 32325339
[TBL] [Abstract][Full Text] [Related]
14. Carboxymethylated tetrahydropyridoindoles as aldose reductase inhibitors: in vitro selectivity study in intact rat erythrocytes in relation to glycolytic pathway.
Juskova M; Snirc V; Gajdosikova A; Gajdosik A; Krizanova L; Stefek M
Gen Physiol Biophys; 2009 Dec; 28(4):325-30. PubMed ID: 20097954
[TBL] [Abstract][Full Text] [Related]
15. Clinical potential of aldose reductase inhibitors in diabetic neuropathy.
Hamada Y; Nakamura J
Treat Endocrinol; 2004; 3(4):245-55. PubMed ID: 16026107
[TBL] [Abstract][Full Text] [Related]
16. Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors.
Balestri F; Quattrini L; Coviello V; Sartini S; Da Settimo F; Cappiello M; Moschini R; Del Corso A; Mura U; La Motta C
Cell Chem Biol; 2018 Nov; 25(11):1414-1418.e3. PubMed ID: 30122369
[TBL] [Abstract][Full Text] [Related]
17. Aldose Reductase: a cause and a potential target for the treatment of diabetic complications.
Thakur S; Gupta SK; Ali V; Singh P; Verma M
Arch Pharm Res; 2021 Jul; 44(7):655-667. PubMed ID: 34279787
[TBL] [Abstract][Full Text] [Related]
18. Structure optimization of tetrahydropyridoindole-based aldose reductase inhibitors improved their efficacy and selectivity.
Majekova M; Ballekova J; Prnova M; Stefek M
Bioorg Med Chem; 2017 Dec; 25(24):6353-6360. PubMed ID: 29074349
[TBL] [Abstract][Full Text] [Related]
19. Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.
Maccari R; Ottanà R
J Med Chem; 2015 Mar; 58(5):2047-67. PubMed ID: 25375908
[TBL] [Abstract][Full Text] [Related]
20. Identification of 2-benzoxazolinone derivatives as lead against molecular targets of diabetic complications.
Vyas B; Choudhary S; Singh PK; Singh B; Bahadur R; Malik AK; Silakari O
Chem Biol Drug Des; 2018 Dec; 92(6):1981-1987. PubMed ID: 30030901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
